Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001047469-17-001857
Filing Date
2017-03-22
Accepted
2017-03-21 18:25:38
Documents
3
Effectiveness Date
2017-03-22

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2231472zdefa14a.htm DEFA14A 35598
2 G327339.JPG g327339.jpg GRAPHIC 4739
3 G1012051.JPG g1012051.jpg GRAPHIC 54180
  Complete submission text file 0001047469-17-001857.txt   118229
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 17705197
SIC: 2834 Pharmaceutical Preparations